Source: Annual Congress 2004 - The spectrum of approaches to molecular and cellular lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Martin Juan, L. Gomez-Izquierdo, C. De la Horra, E. Calderon, E. Rodriguez-Becerra, F. Rodriguez-Panadero, J. Castillo (Seville, Spain). Role of pneumocystis jiroveci in interstitial lung disease. Eur Respir J 2004; 24: Suppl. 48, 3443

Member's Comments

No comment yet.

Related content which might interest you: Assessement of pulmonary TB in association with pneumocystis jiroveci Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008 Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Pulmonary embolism or Pneumocystis jiroveci pneumonia? Source: ISSN=ISSN 1810-6838, ISBN=, page=83 Year: 2006 99mTc-DTPA lung clearance test: Role in the diagnosis of Pneumocystis carinii pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 591s Year: 2003 Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Pneumocystis jirovecii Source: Respipedia Article Year: 2018 Pneumocystis jiroveci colonisation in Turkish patients with primary pulmonary disorders Source: Eur Respir J 2005; 26: Suppl. 49, 411s Year: 2005 Pneumocystis carinii pneumonia complicating thoracic external radiotherapy for lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of Pneumocystis carinii pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 336s Year: 2003 Pneumocystis carinii pneumonia in an otherwise healthy patient Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Usefulness of measurement of serum (1®3)β-D-glucan in the diagnosis of pneumocystis jiroveci pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 559s Year: 2006 Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019 Year: 2020 Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Pneumocystis carinii (jiroveci) pneumonia (PCP) in ICU patients with hematological malignancies Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues Source: Eur Respir J 2003; 21: 204-208 Year: 2003 Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients Source: Eur Respir J 2002; 20: 982-989 Year: 2002 Pneumocystis jirovecii infection Source: Eur Respir Monogr 2014; 66: 138-152 Year: 2014 Cell-mediated immunity in patients with Pneumocystis jirovecii pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013